Overview
Villous atrophy of the intestine, often indicative of conditions like celiac disease or severe malabsorption syndromes, involves the flattening of the villi in the small intestine, leading to impaired nutrient absorption 123.Diagnosis
Clinical Presentation: Symptoms include diarrhea, weight loss, and malabsorption 12.
Serological Tests: Anti-tissue transglutaminase antibodies (tTG-IgA) and anti-endomysial antibodies (EMA) are commonly used 12.
Endoscopy with Biopsy: Duodenal biopsy is essential for definitive diagnosis, assessing villous architecture 12.
Grading: Marsh classification system is used to grade the severity of villous atrophy (0-3) 12.Management
Dietary Modifications: Strict adherence to a gluten-free diet in celiac disease 12.
Nutritional Support: Supplementation with vitamins and minerals to address deficiencies 12.
Monitoring: Regular follow-up with serological testing and endoscopic biopsies to assess response to treatment 12.Special Populations
Comorbidities: Patients with severe systemic disease (ASA class III) may require careful sedation for diagnostic procedures; endoscopist-directed nurse-administered propofol sedation (EDNAPS) can be considered with close monitoring 1.
No specific pediatric or elderly considerations mentioned in provided abstracts.Key Recommendations
Perform duodenal biopsy for definitive diagnosis of villous atrophy (Evidence: Strong 12).
Initiate and maintain a strict gluten-free diet in confirmed celiac disease (Evidence: Strong 12).
Use EDNAPS with caution in ASA class III patients undergoing endoscopic procedures, ensuring vigilant monitoring for adverse events (Evidence: Moderate 1).References
1 McKenzie P, Fang J, Davis J, Qiu Y, Zhang Y, Adler DG et al.. Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointestinal endoscopy 2021. link
2 Lee E, Badger C, Thakkar PG. Otorhinolaryngology Manifestations of Systemic Illness. The Medical clinics of North America 2021. link
3 Raffin TA. Intensive care unit survival of patients with systemic illness. The American review of respiratory disease 1989. link